Stay updated on CC-486 and Venetoclax for AML Clinical Trial
Sign up to get notified when there's something new on the CC-486 and Venetoclax for AML Clinical Trial page.

Latest updates to the CC-486 and Venetoclax for AML Clinical Trial page
- Check6 days agoChange DetectedThe record history now shows an added Revision: v3.3.4 and removal of Revision: v3.3.3. This is a minor log update to the page's revisions; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded Revision: v3.3.3 to the Study Record Versions and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page history shows a new revision entry (v3.3.2) and removal of the prior revision (v3.2.0), reflecting internal record-keeping. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the site-wide government funding/operating status notice from the page; this deletion does not affect the displayed trial details or history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check85 days agoChange DetectedThe latest screenshot shows an additional entry in the Study Record Versions list, indicating a new version submitted on 2025-01-02, which is a routine history update reflecting ongoing maintenance of the record and does not alter the study's content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check106 days agoChange DetectedVersion bump to v3.2.0 accompanied by a government-operating-status notice; replaces the earlier v3.1.0 tag.SummaryDifference13%

Stay in the know with updates to CC-486 and Venetoclax for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-486 and Venetoclax for AML Clinical Trial page.